Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis
- PMID: 24034549
- DOI: 10.1016/j.crad.2013.07.022
Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis
Abstract
The internationally accepted diagnostic criteria for hepatocellular carcinoma (HCC) in cirrhosis are highly accurate for large tumours, but offer relatively low sensitivity for small (<2 cm) tumours. Diffusion-weighted imaging (DWI) is a functional magnetic resonance imaging (MRI) technique that has been studied extensively as an aid to visualize various abdominal malignancies, including HCC in cirrhosis. DWI maps water diffusivity, which in HCC may be restricted as a result of changes ensuing from hepatocarcinogenesis. The present review is based on up-to-date evidence and describes the strengths and weaknesses of DWI, both as a standalone technique and as an adjunct sequence to conventional protocols, in the diagnosis, staging, prognostication, and assessment of treatment response of HCC in cirrhosis.
Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671. J Comput Assist Tomogr. 2010. PMID: 20657216
-
Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.Acta Radiol. 2012 Oct 1;53(8):830-8. doi: 10.1258/ar.2012.120099. Epub 2012 Jul 30. Acta Radiol. 2012. PMID: 22847903
-
Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.Acta Radiol. 2013 Mar 1;54(2):127-36. doi: 10.1258/ar.2012.120262. Epub 2012 Nov 12. Acta Radiol. 2013. PMID: 23148300
-
A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases.J Gastroenterol Hepatol. 2013 Feb;28(2):227-34. doi: 10.1111/jgh.12054. J Gastroenterol Hepatol. 2013. PMID: 23190006 Review.
-
Imaging of HCC.Abdom Imaging. 2012 Apr;37(2):215-30. doi: 10.1007/s00261-011-9794-x. Abdom Imaging. 2012. PMID: 21909721 Review.
Cited by
-
Quantitative diffusion weighted imaging in patients with hepatocellular carcinoma: effects of simultaneous multi-slice acceleration and gadoxetic acid administration.Abdom Radiol (NY). 2024 Mar;49(3):683-693. doi: 10.1007/s00261-023-04100-y. Epub 2023 Nov 6. Abdom Radiol (NY). 2024. PMID: 37930449
-
Prognostication and response assessment in liver and pancreatic tumors: The new imaging.World J Gastroenterol. 2015 Jun 14;21(22):6794-808. doi: 10.3748/wjg.v21.i22.6794. World J Gastroenterol. 2015. PMID: 26078555 Free PMC article. Review.
-
Advances in the early diagnosis of hepatocellular carcinoma.Genes Dis. 2020 Jan 27;7(3):308-319. doi: 10.1016/j.gendis.2020.01.014. eCollection 2020 Sep. Genes Dis. 2020. PMID: 32884985 Free PMC article. Review.
-
Diffusion-weighted imaging of the liver: techniques and applications.Magn Reson Imaging Clin N Am. 2014 Aug;22(3):373-95. doi: 10.1016/j.mric.2014.04.009. Magn Reson Imaging Clin N Am. 2014. PMID: 25086935 Free PMC article. Review.
-
Contrast Enhanced MRI in the Diagnosis of HCC.Diagnostics (Basel). 2015 Sep 21;5(3):383-98. doi: 10.3390/diagnostics5030383. Diagnostics (Basel). 2015. PMID: 26854161 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical